OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 1 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q1 2009. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $29,000 | -97.5% | 5,000 | -92.2% | 0.02% | -96.0% |
Q3 2015 | $1,182,000 | -5.1% | 64,000 | 0.0% | 0.48% | +19.5% |
Q2 2015 | $1,245,000 | +8.9% | 64,000 | -1.5% | 0.40% | +44.4% |
Q1 2015 | $1,143,000 | -12.8% | 65,000 | -20.7% | 0.28% | +6.5% |
Q4 2014 | $1,311,000 | -0.6% | 82,000 | 0.0% | 0.26% | +130.1% |
Q4 2013 | $1,319,000 | -3.3% | 82,000 | 0.0% | 0.11% | +8.7% |
Q3 2013 | $1,364,000 | +65.1% | 82,000 | 0.0% | 0.10% | +50.7% |
Q2 2013 | $826,000 | -3.2% | 82,000 | 0.0% | 0.07% | +15.0% |
Q1 2013 | $853,000 | +15.9% | 82,000 | 0.0% | 0.06% | +1.7% |
Q4 2012 | $736,000 | -18.8% | 82,000 | 0.0% | 0.06% | -15.7% |
Q3 2012 | $906,000 | +0.7% | 82,000 | 0.0% | 0.07% | -4.1% |
Q2 2012 | $900,000 | +114.3% | 82,000 | 0.0% | 0.07% | +121.2% |
Q1 2012 | $420,000 | -4.3% | 82,000 | 0.0% | 0.03% | -13.2% |
Q4 2011 | $439,000 | -56.8% | 82,000 | -50.0% | 0.04% | -22.4% |
Q3 2011 | $1,017,000 | -8.5% | 164,000 | 0.0% | 0.05% | -5.8% |
Q2 2011 | $1,111,000 | +86.7% | 164,000 | +100.0% | 0.05% | +8.3% |
Q1 2011 | $595,000 | -6.9% | 82,000 | 0.0% | 0.05% | -14.3% |
Q4 2010 | $639,000 | +5.3% | 82,000 | 0.0% | 0.06% | -3.4% |
Q1 2010 | $607,000 | +3.8% | 82,000 | 0.0% | 0.06% | 0.0% |
Q4 2009 | $585,000 | +7.1% | 82,000 | 0.0% | 0.06% | +5.5% |
Q3 2009 | $546,000 | -50.3% | 82,000 | 0.0% | 0.06% | -58.3% |
Q2 2009 | $1,099,000 | +39.6% | 82,000 | +43.9% | 0.13% | +12.8% |
Q1 2009 | $787,000 | – | 57,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|